Marco de Morpurgo focuses on government regulation of the life sciences industry. He has a broad European practice and regularly supports clients on global multijurisdictional projects.
He is both EU and US qualified and, over the past 12 years, has practised in Brussels, London, Paris and Rome.
Marco’s clients include established and emerging pharmaceutical, biotechnology and medical device companies, and service providers looking to expand their operations in Europe and internationally.
He helps clients navigate the complex regulatory structures governing the...
Marco de Morpurgo focuses on government regulation of the life sciences industry. He has a broad European practice and regularly supports clients on global multijurisdictional projects.
He is both EU and US qualified and, over the past 12 years, has practised in Brussels, London, Paris and Rome.
Marco’s clients include established and emerging pharmaceutical, biotechnology and medical device companies, and service providers looking to expand their operations in Europe and internationally.
He helps clients navigate the complex regulatory structures governing the life sciences industry, providing strategic and compliance advice in a wide range of areas including R&D, product classifications and approvals, regulatory incentives, market access, promotion and advertising, as well as industry-specific ethical rules.
As Co-Chair of DLA Piper’s global Life Sciences practice, Marco leads a team of more than 300 lawyers, providing coordinated advice and innovative solutions to clients in over 40 jurisdictions worldwide.
He is a member of the Editorial Board of the European Health & Pharmaceutical Law Review and teaches Life Sciences Law at HEC Paris.